By Professor Phillip David Stricker

Preprints

Huang R; Bornman MSR; Stricker P; Brum IS; Mutambirwa S; Jaratlerdsiri W; Hayes V, 2023, The impact of telomere length on prostate cancer aggressiveness, genomic instability and health disparities, , http://dx.doi.org/10.21203/rs.3.rs-3534553/v1

Zhang K; Stricker P; Lohr M; Stehling M; Suberville M; Cussenot O; Lunelli L; Ng CF; Teoh J; Laguna P; Rosette JDL, 2023, A multi-center international study to evaluate the safety, functional and oncological outcomes of Irreversible Electroporation for the ablation of prostate cancer, , http://dx.doi.org/10.21203/rs.3.rs-3248717/v1

Craddock J; Jiang J; PATRICK S; Mutambirwa S; Stricker PD; Bornman R; Jaratlerdsiri W; Hayes VM, 2023, Alterations in the Epigenetic Machinery Associated With Prostate Cancer Health Disparities, , http://dx.doi.org/10.20944/preprints202305.1875.v1

Hayes V; Jaratlerdsiri W; Jiang J; Gong T; Patrick S; Willet C; Chew T; Lyons R; Haynes A-M; Pasqualim G; Louw M; Kench J; Campbell R; Chan E; Wedge D; Sadsad R; Brum I; Mutambirwa S; Stricker P; Bornman R; Horvath L, 2021, African-specific prostate cancer molecular taxonomy, , http://dx.doi.org/10.21203/rs.3.rs-1122619/v1

Li L; Shiradkar R; Tirumani SH; Bittencourt LK; Fu P; Mahran A; Buzzy C; Stricker PD; Rastinehad AR; Magi-Galluzzi C; Ponsky L; Klein E; Purysko AS; Madabhushi A, Title of the Manuscript Novel Radiomic Analysis on Bi-Parametric MRI for Characterizing Differences between MR Non-Visible and Visible Clinically Significant Prostate Cancer, , http://dx.doi.org/10.2139/ssrn.4180483

Back to profile page